Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/21/2025

Management of Klebsiella Pneumoniae Prostatitis

Epidemiological Context

  • The microbial spectrum in complicated urinary tract infections and prostatitis includes Klebsiella species alongside E. coli, Proteus, Pseudomonas, Serratia, and Enterococcus, as reported by the European Association of Urology 1

Clinical Significance and Treatment

  • Carbapenem-resistant Klebsiella pneumoniae (CRKP) represents an emerging concern in healthcare-associated infections, according to the European Society of Clinical Microbiology and Infectious Diseases 2, 3

Diagnostic Approach

  • The European Association of Urology recommends performing midstream urine culture in acute bacterial prostatitis to identify the causative organism and guide antibiotic selection 4, 5
  • The European Association of Urology suggests using the Meares-Stamey 2- or 4-glass test for chronic bacterial prostatitis diagnosis to confirm prostatic localization of infection, although this is also supported by Praxis Medical Insights, the European Urology guideline is preferred 5

Treatment Considerations

  • The European Association of Urology states that treatment duration for complicated UTIs including prostatitis should be 7-14 days, though chronic bacterial prostatitis requires longer courses 1

Key Clinical Pitfalls

  • The European Association of Urology advises against performing prostatic massage in acute bacterial prostatitis as this can precipitate bacteremia 4, 5